Status:
COMPLETED
ICSI Versus Conventional IVF in Non-male Factor Couples
Lead Sponsor:
Mỹ Đức Hospital
Collaborating Sponsors:
An Sinh Hospital
Conditions:
Infertility
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Conventionally, ICSI was initially developed and has been shown to be an effective treatment for male factor infertility. It is increasingly being used for patients without a male factor diagnosis, de...
Detailed Description
All patients undergoing IVF/ICSI will be treated with a GnRH antagonist protocol. Recombinant FSH (Puregon, MSD) will be given on day 2 or day 3 of menstrual cycle for 5 days. The starting dose is ind...
Eligibility Criteria
Inclusion
- Having ≤ 2 IVF/ICSI cycles
- Total sperm count and motility are normal (WHO, 2010)
- Antagonist protocol
- Agree to have ≤ 2 embryos transferred
- Not participating in another IVF study at the same time
Exclusion
- In-vitro maturation (IVM) cycles
- Using frozen semen
- Poor fertilization in previous cycle (≤ 25%)
Key Trial Info
Start Date :
March 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 12 2020
Estimated Enrollment :
1064 Patients enrolled
Trial Details
Trial ID
NCT03428919
Start Date
March 16 2018
End Date
August 12 2020
Last Update
October 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dang Q Vinh
Hochiminh City, Vietnam